Updated international Cancer of the Pancreas Screening (CAPS) consortium guidelines on the management of patients with increased risk for familial pancreatic cancer

(1) Erasmus University Medical Center,Rotterdam,Netherlands

(2) Johns Hopkins Medicine - Gastroenterology,Baltimore,United States

(3) Universitätsklinikum Giessen und Marburg VTG-Chirurgie,Marburg,Germany

(4) University of Pittsburgh Medical Center,Pittsburgh,United States

(5) Ramón y Cajal University Hospital,Madrid,Spain

(6) University of Colorado Anschutz Medical Campus,Aurora,United States

(7) Yale University,New Haven,United States

(8) Johns Hopkins University School of Medicine,Baltimore,United States

(9) Amsterdam UMC,Amsterdam,Netherlands

(10) Philipps Universität Marburg,Marburg,Germany

(11) Columbia University Medical Center,New York,United States

(12) University of Pennsylvania Perelman School of Medicine,Philadelphia,United States

(13) Dana-Farber Cancer Institute, Harvard Medical School,Boston,United States

(14) Leiden University Medical Center,Leiden,Netherlands

(15) University Medical Center Rotterdam,Rotterdam,Netherlands

(16) John Hopkins Hospital,Baltimore,United States

This item was part of the Frontiers in pancreatic neoplasia session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019